Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash
ECHEMI chemical news

Market Flash

Anti-aging drugs, saving 3 years stolen by the new crown

Anti-aging drugs, saving 3 years stolen by the new crown

2023-02-01

The new crown accelerates aging by 3-4 years.

Cosmos Pharmaceutical Factory' has revenue of more than 100 billion US dollars in 2022, and 56.7 billion US dollars of new crown-related revenue!
Raise 3 billion to build resin and other projects! Another chemical company rushes to IPO!

Raise 3 billion to build resin and other projects! Another chemical company rushes to IPO!

2023-01-30

Qingdao Gulf Chemical Co., Ltd. (or the "Company") recently submitted an initial public offering prospectus (declaration draft).

Chinese products will be presented at Prodexpo Food in Moscow

Chinese products will be presented at Prodexpo Food in Moscow

2023-01-29

The website of the organizer of the Moscow Prodexpo food exhibition announced that Chinese products will be unveiled at the exhibition.

Why is the rate of prescription of Paxlovid to new crown patients by British and American doctors so low?
BB-1709 for injection was approved for clinical practice

BB-1709 for injection was approved for clinical practice

2023-01-29

The application for BB-1709 IND, an innovative drug of Bristiscon anti-tumor ADC, was approved by the State Food and Drug Administration of China.

The United States exempts residue limits for malic acid

The United States exempts residue limits for malic acid

2023-01-29

According to the Federal Register, on January 25, 2023, the EPA issued Regulation 2023-01155, exempting the residue limit of malic acid.

The treatment population of 'mabaloxavir' has expanded, and how much has the global anti-influenza drug progressed?
2022 inventory: those license-out of 'borrowing ships to go to sea'

2022 inventory: those license-out of 'borrowing ships to go to sea'

2023-01-28

With the rapid development of China's medicine, domestic pharmaceutical companies have gradually had fierce competition and serious involvement.

2022 inventory: The market value of A-share CXO lost 300 billion, and only 6 stock prices achieved positive growth...

2022 inventory: The market value of A-share CXO lost 300 billion, and only 6 stock prices achieved positive growth...

2023-01-28

19 companies fell, accounting for 76%, with an average decline of more than 37%.

Annual inventory: 19 drugs were rejected by the FDA in 2022; Involving Merck, Gilead, Cinda...
Synthetic lethal' emerging target - PRMT5 development geometry?

Synthetic lethal' emerging target - PRMT5 development geometry?

2023-01-28

The research on PRMT5 small molecule inhibitors has become a hot spot in the research and development of anti-tumor drugs.

British Skincare Brand FACETHEORY Signs Exclusive Retail Partnership Agreement with Sephora Asia
THE ESTEE LAUDER COMPANIES NAMES VP/GM OF JO MALONE LONDON UK & IRELAND
ELEMIS ANNOUNCES STATUS AS A CERTIFIED B CORP
APTAR WINS AWARDS FOR RECYCLABLE, MONO-MATERIAL LOTION PUMP
Best of its kind – Bytovi

Best of its kind – Bytovi

2023-01-28

The story of new drugs

CDMO Secret War: Wu Xi, Haoyuan, Kai Lai Ying... Compete for ADC

CDMO Secret War: Wu Xi, Haoyuan, Kai Lai Ying... Compete for ADC

2023-01-28

ADC is a fire in the winter of domestic innovative drugs.

Inventory: New drugs approved by the NMPA in 2022

Inventory: New drugs approved by the NMPA in 2022

2023-01-28

The year of the rise of original innovative drugs

In 2023, the competition in the medicine circle is fierce, who will take the crown of 'medicine king'?

In 2023, the competition in the medicine circle is fierce, who will take the crown of 'medicine king'?

2023-01-28

A new star rises, the "medicine king" changes owners, and the sky changes in 2023?

  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.